Abstract MPTH62: Midlife Resistance Exercise Behaviors and Incident Heart Failure with Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study

D DJ McDonough (University of Minnesota, Roseville, Minnesota, United States) F Francis Ryan Avenido (University of Minnesota, Minneapolis, Minnesota, United States) R Ryan Demmer (Mayo Clinic, Rochester, Minnesota, United States) K Kelley Gabriel (University of Alabama at Birmingham, Birmingham, Alabama, United States) L Lisa VanWagner (UT Southwestern Medical Center, Dallas, Texas, United States) B Barry Borlaug (Mayo Clinic, Rochester, Minnesota, United States) S Steven Stovitz (University of Minnesota Med Sch, Minneapolis, Minnesota, United States) M Markus Meyer (University of Minnesota Med Sch, Minneapolis, Minnesota, United States) D Darin Erickson (University of Minnesota, Roseville, Minnesota, United States) P Priya Palta (UNC Chapel Hill, Chapel Hill, North Carolina, United States) M Mark Pereira (University of Minnesota, Roseville, Minnesota, United States)

Abstract

Introduction: Heart failure (HF) with preserved ejection fraction (HFpEF) is now the predominant HF subtype, largely driven by the syndemic of physical inactivity and overweight/obesity in an aging population. Deranged skeletal muscle energetics and regional ectopic adipose depots are key cardiometabolic pathways in the pathogenesis of HFpEF, both of which may be favorably modified by 1-2 hours/week of resistance exercise (RE). However, its association with HFpEF risk has not been thoroughly examined. We investigated the association between midlife RE behaviors and incident HFpEF in the Atherosclerosis Risk in Communities (ARIC) study. Hypothesis: Participation in RE at midlife is inversely associated with the risk of incident HFpEF. Methods: Our exposure (RE)—including weightlifting and bodyweight resistance exercises—was assessed using the validated Baecke questionnaire and reported weekly RE duration was averaged across Visits 1 and 3 (1987-1995). We dichotomized averaged RE as 0 hr/wk (‘No RE’, reference) and >0 hr/wk (‘Any RE’). Our outcome (incident HFpEF) was identified through committee-adjudicated HF hospitalizations (January 1, 2005 to December 31, 2023) using medical chart abstraction. Participants with prevalent HF, death, or loss to follow-up before January 1, 2005 were excluded. We constructed Cox regression models to evaluate the association between midlife RE and incident HFpEF. Model 1 adjusted for age, sex, race, field center, education, smoking status, alcohol consumption, and non-RE physical activity. Given that adiposity may lie on the causal pathway, waist-height ratio (WHtR; both measured in cm) was added in Model 2. Results: 10,751 Black and White participants (803 incident HFpEF cases) were analyzed over a median follow-up time of 14.4 years (mean±SD Visit 1 age, 53.3±5.6 years; average Visit 1 and 3 WHtR, 0.58±0.08; 24.7% Black; 57.4% female). 1,217 participants (11.3%) reported engaging in RE at Visits 1 and/or 3, with a median duration of 0.84 hr/wk (IQR, 0.50-1.61). Compared to No RE, the fully adjusted hazard ratio (HR) for Model 1 for Any RE was: 0.78 (95% CI, 0.61-1.00, P = 0.05). The association was attenuated after adjustment for WHtR: HR = 0.84 (0.65-1.07, P = 0.16). Conclusion: Participation in RE at midlife is associated with a 22% lower risk of incident HFpEF. To inform public health and clinical guidelines, further studies are needed to clarify the role of RE in HFpEF prevention.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

D

DJ McDonough

University of Minnesota, Roseville, Minnesota, United States

F

Francis Ryan Avenido

University of Minnesota, Minneapolis, Minnesota, United States

R

Ryan Demmer

Mayo Clinic, Rochester, Minnesota, United States

K

Kelley Gabriel

University of Alabama at Birmingham, Birmingham, Alabama, United States

L

Lisa VanWagner

UT Southwestern Medical Center, Dallas, Texas, United States

B

Barry Borlaug

Mayo Clinic, Rochester, Minnesota, United States

S

Steven Stovitz

University of Minnesota Med Sch, Minneapolis, Minnesota, United States

M

Markus Meyer

University of Minnesota Med Sch, Minneapolis, Minnesota, United States

D

Darin Erickson

University of Minnesota, Roseville, Minnesota, United States

P

Priya Palta

UNC Chapel Hill, Chapel Hill, North Carolina, United States

M

Mark Pereira

University of Minnesota, Roseville, Minnesota, United States